Amy Randall
Family · Toledo, OHNPI 1164723219
Payments from drug & device makers
Across 84 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$176
- Amgen$153
- Seagen Inc.$152
- Daiichi Sankyo Inc.$152
- E.r. Squibb & Sons, L.L.C.$152
- Merck$135
- plus $740 from 23 others
What the payments were for
- Food & beverage$1,38684%
- Education$27416%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $176 |
| Amgen | 5 | $153 |
| Seagen Inc. | 5 | $152 |
| Daiichi Sankyo Inc. | 8 | $152 |
| E.r. Squibb & Sons, L.L.C. | 4 | $152 |
| Merck | 6 | $135 |
| Genentech USA, Inc. | 14 | $109 |
| Astellas Pharma US Inc | 1 | $90 |
| AstraZeneca | 3 | $54 |
| Lilly USA, LLC | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Pfizer | 3 | $43 |
| Johnson & Johnson | 2 | $41 |
| Myovant Sciences Inc. | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $37 |
| Taiho Oncology, Inc. | 1 | $23 |
| Sobi, Inc | 1 | $21 |
| Sanofi | 1 | $21 |
| AbbVie | 1 | $19 |
| Mirati Therapeutics, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $17 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $15 |
| Dova Pharmaceuticals | 1 | $15 |
| Gilead | 1 | $14 |
| G1 Therapeutics, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $12 |
| Morphosys, US Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reblozyl$108
How this compares
$1,660 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 23 | $7,091 |
| Anastrozole | 36 | $1,574 |
| Tamoxifen Citrate | 12 | $471 |
| Hydroxyurea | 16 | $432 |
| Acyclovir | 24 | $307 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other family in Toledo
- Kirt MunsonToledo$108K
- Sheri LukeToledo$31K
- Kyle PatchenToledo$25K
- Alexander NorwoodToledo$17K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.